Lipids catapulted toward the top of the world’s health-care priority list because the COVID-19 vaccines from Pfizer, Moderna and others can’t do their job without them.
A look at the latest economic stimulus package, proposed by the Biden Administration and being shepherded through a divided Congress, with John Rosen, adjunct professor and director of The Liberty Initiative in the Pompea College of Business Economics Department at the University of New Haven.
Cheryl Druehl, associate professor of operations management at George Mason University’s School of Business, details the many ways that distribution of the COVID-19 vaccine went wrong — and the lessons to be learned from it.
Sylvie Thompson, vice president-transformation with NTT Data Services, proposes a “Starbucks-instead-of-stadium” approach to distributing and administering the COVID-19 vaccine.
In the race to get people immunized in the U.S., pharmacists made a key discovery — that vials of Pfizer Inc.’s COVID-19 vaccine contain an extra dose. Extracting that extra bit of vaccine, however, hinges upon the availability of a specialized syringe that is in short supply.
The latest supply-chain news, analysis, trends and tools for executives in the healthcare industry. Learn how healthcare companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.